Stock Information
Biogen Inc (BIIB)
Ticker Symbol: BIIB
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $29,962.95 mil
Piotroski score: 4
PE Ratio: 37.1996
EPS (TTM): 5.6469
Revenue (TTM): $67.44 M
Dividend Yield: N/A%
ROE: 4.51%
Latest News
-
Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Thu, Aug 13, 2026 1:52 PM
-
Wolfe Research Upgrades Biogen to Outperform, Announces $300 Price Target
Thu, Aug 13, 2026 1:18 PM
-
NovelMed Advances NM5072 for Multiple Ocular Disorders
Tue, Aug 11, 2026 7:27 PM
-
Biogen (BIIB) Q2 2026 Earnings Call Transcript
Sat, Aug 8, 2026 12:02 AM
Key Financials
Financial data not available
